Accrol Group Holdings PLC Director's Dealing (2527L)
September 29 2016 - 11:33AM
UK Regulatory
TIDMACRL
RNS Number : 2527L
Accrol Group Holdings PLC
29 September 2016
This announcement contains inside information
Accrol Group Holdings plc (the "Company" or "Accrol")
Director's Dealing
Accrol Group Holdings plc, the AIM listed leading independent
tissue converter, is pleased to announce that is has been notified
that Stephen Crossley, CEO of Accrol, has purchased 100,000
ordinary shares of GBP0.001 each ("Ordinary Shares") via his SIPP
on 29(th) September 2016 at a price of 132p per Ordinary Share.
Following this transaction, Stephen has an interest in 100,000
Ordinary Shares, representing approximately 0.1 per cent. of the
Company's issued Ordinary Share capital.
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
1 Details of the person discharging
managerial responsibilities
/ person closely associated
--- -----------------------------------------------------
a) Name Stephen Crossley
--- ----------------------- ----------------------------
2 Reason for the notification
--- -----------------------------------------------------
a) Position/status CEO
--- ----------------------- ----------------------------
b) Initial notification Initial notification
/Amendment
--- ----------------------- ----------------------------
3 Details of the issuer, emission
allowance market participant,
auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------
a) Name Accrol Group Holdings plc
--- ----------------------- ----------------------------
b) LEI (Pending)
--- ----------------------- ----------------------------
4 Details of the transaction(s):
section to be repeated for (i)
each type of instrument; (ii)
each type of transaction; (iii)
each date; and (iv) each place
where transactions have been
conducted
--- -----------------------------------------------------
a) Description Ordinary shares of GBP0.001
of the financial
instrument, ISIN: GB00BZ6VT592
type of instrument
Identification
code
--- ----------------------- ----------------------------
b) Nature of the Purchase of Ordinary Shares
transaction
--- ----------------------- ----------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
132p 100,000
--------- ----------
--- ----------------------- ----------------------------
d) Aggregated information
- Aggregated N/A - single transaction
volume
- Price
--- ----------------------- ----------------------------
e) Date of the 29th September 2016
transaction
--- ----------------------- ----------------------------
f) Place of the London Stock Exchange,
transaction AIM
--- ----------------------- ----------------------------
For further information
please contact:
Zeus Capital Limited (Nominated
Adviser & Broker)
Dan Bate / Jonathan Sharp Tel: +44 (0) 161 831
1512
Dominic King / Adam Pollock Tel: +44 (0) 20 3829
/ Mike Seabrook 5000
Camarco (Media enquiries)
Jennifer Renwick / Billy Tel: +44 (0) 203 757
Clegg 4994
Notes to Editors
Accrol manufactures toilet rolls, kitchen rolls and facial
tissues as well as other tissue products at the Company's 350,000
sq. ft. manufacturing, storage and distribution facility in
Blackburn, Lancashire. Accrol currently manufactures approximately
16 million units per week and supplies some of the UK's largest
retailers, providing both Accrol branded and Private Label
products.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBUGDCGXDBGLC
(END) Dow Jones Newswires
September 29, 2016 11:33 ET (15:33 GMT)
Accrol (LSE:ACRL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2023 to Apr 2024